Infectious risk in xenotransplantation - What post-transplant screening for the human recipient?

Xenotransplantation

Volumn 18, Issue 3, 2011, Pages 151-157

  Denner, Joachim ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

detection methods; porcine endogenous retroviruses (PERV); transpecies transmission; virus safety of xenotransplantation

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 70; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

BREEDING; DISEASE TRANSMISSION; ENDOGENOUS RETROVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FELINE LEUKEMIA VIRUS; GRAFT RECIPIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE TEST; INFECTION RISK; NONHUMAN; NORTHERN BLOTTING; PORCINE ENDOGENOUS RETROVIRUS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SCREENING; SWINE; VIRUS; VIRUS TRANSMISSION; WESTERN BLOTTING; XENOTRANSPLANTATION; XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS;

ANIMALS; ENDOGENOUS RETROVIRUSES; HUMANS; IMMUNOSUPPRESSION; RETROVIRIDAE INFECTIONS; RISK FACTORS; SWINE; SWINE DISEASES; TRANSPLANTATION, HETEROLOGOUS;

EID: 79959762066     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2011.00636.x     Document Type: Review

References (60)

1. Klymiuk N, Aigner B, Brem G, Wolf E,. Genetic modification of pigs as organ donors for xenotransplantation. Mol Reprod Dev 2010; 77: 209-221.
2. Petersen B, Carnwath JW, Niemann H,. The perspectives for porcine-to-human xenografts. Comp Immunol Microbiol Infect Dis 2009; 32: 91-105.
3. Tucker A, Belcher C, Moloo B, et al., The production of transgenic pigs for potential use in clinical xenotransplantation: microbiological evaluation. Xenotransplantation 2002; 9: 191-202. (Pubitemid 36358960)
4. Denner J,. Xenotransplantation: state of the art of biosafety. In:, Jansen ES, Simon JW, eds. Xenotransplantation-Ethic, Economic, Social, Cultural and Scientific Background, Vol. 1. Saarbrücken: VDM-Verlag, 2008: 7-79.
5. Schuurman HJ,. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-chapter 2: source pigs. Xenotransplantation 2009; 16: 215-222.
6. Finsterbusch T, Mankertz A,. Porcine circoviruses-small but powerful. Virus Res 2009; 143: 177-183.
7. Tucker AW, McNeilly F, Meehan B, et al., Methods for the exclusion of circoviruses and gammaherpesviruses from pigs. Xenotransplantation 2003; 10: 343.
8. Chmielewicz B, Goltz M, Lahrmann KH, Ehlers B,. Approaching virus safety in xenotransplantation: a search for unrecognized herpesviruses in pigs. Xenotransplantation 2003; 10: 349-356. (Pubitemid 36903775)
9. Swindle MM,. Defining appropriate health status and management programs for specific pathogen-free swine for xenotransplantation. Ann N Y Acad Sci 1998; 862: 111-120. (Pubitemid 29044018)
10. PHS Guideline on Infectious Disease Issues in Xenotransplantation. January, 19, 2001.
11. OECD/WHO Consultation on Xenotransplantation Surveillance: Summary. October, 26, 2001.
12. Scobie L, Takeuchi Y,. Porcine endogenous retrovirus and other viruses in xenotransplantation. Curr Opin Organ Transplant 2009; 14: 175-179.
13. Meng XJ,. Swine hepatitis E virus: cross-species infection and risk in xenotransplantation. Curr Top Microbiol Immunol 2003; 278: 185-216. (Pubitemid 36950678)
14. Zhang W, Shen Q, Hua X, et al., The first Chinese porcine sapovirus strain that contributed to an outbreak of gastroenteritis in piglets. J Virol 2008; 82: 8239-8240.
15. Barrette RW, Metwally SA, Rowland JM, et al., Discovery of swine as a host for the Reston ebolavirus. Science 2009; 325: 204-206.
16. Patience C, Switzer WM, Takeuchi Y, et al., Multiple groups of novel retroviral genomes in pigs and related species. Virol 2001; 75: 2771-2775. (Pubitemid 32185040)
17. Patience C, Takeuchi Y, Weiss RA,. Infection of human cells by an endogenous retrovirus of pigs. Nat Med 1997; 3: 282-286. (Pubitemid 27112924)
18. Denner J,. Transspecies transmissions of retroviruses: new cases. Virology 2007; 369: 229-233. (Pubitemid 350087189)
19. Hahn BH, Shaw GM, De Cock KM, Sharp PM,. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287: 607-614. (Pubitemid 30070900)
20. Denner J, Schuurman H, Patience C,. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 5: strategies to prevent transmission of porcine endogenous retroviruses. Xenotransplantation 2009; 16: 239-248.
21. Tacke SJ, Specke V, Denner J,. Differences in release and determination of subtype of porcine endogenous retroviruses produced by stimulated normal pig blood cells. Intervirology 2003; 46: 17-24. (Pubitemid 36173473)
22. Harrison I, Takeuchi Y, Bartosch B, Stoye JP,. Determinants of high titer in recombinant porcine endogenous retroviruses. J Virol 2004; 78: 13871-13879. (Pubitemid 39612784)
23. Wood JC, Quinn G, Suling KM, et al., Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine. J Virol 2004; 78: 2494-2501. (Pubitemid 38228943)
24. Denner J,. Recombinant porcine endogenous retroviruses (PERV-A/C): a new risk for xenotransplantation? Arch Virol 2008; 153: 1421-1426.
25. Kaulitz D, Mihica D, Dorna J, et al., Development of sensitive methods for detection of porcine endogenous retrovirus-C (PERV-C) in the genome of pigs J Virol Methods (in press) 2011.
26. Fiebig U, Stephan O, Kurth R, Denner J,. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses [PERVs]: basis for a vaccine for xenotransplantation? Virology 2003; 307: 406-413. (Pubitemid 36344171)
27. Kaulitz D, Fiebig U, Eschricht M, et al., Generation of neutralising antibodies against porcine endogenous retroviruses [PERVs]. Virology 2011; 411: 78-86.
28. Ramsoondar J, Vaught T, Ball S, et al., Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs. Xenotransplantation 2009; 16: 164-180.
29. Dieckhoff B, Karlas A, Petersen B, et al., Knockdown of porcine endogenous retrovirus [PERV] expression by PERV-specific shRNA in transgenic pigs. Xenotransplantation 2008; 15: 36-45. (Pubitemid 351360240)
30. Stephan O, Schwendemann J, Specke V, et al., Porcine endogenous retroviruses (PERVs): generation of specific antibodies, development of an immunoperoxidase assay (IPA) and inhibition by AZT. Xenotransplantation 2010; 8: 310-316.
31. Powell SK, Gates ME, Langford G, et al., Antiretroviral agents inhibit infection of human cells by porcine endogenous retroviruses. Antimicrob Agents Chemother 2000; 44: 3432-3433. (Pubitemid 33009506)
32. Qari SH, Magre S, García-Lerma JG, et al., Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. J Virol 2001; 75: 1048-1053. (Pubitemid 32037308)
33. Rémy S, Tesson L, Ménoret S, Usal C, Scharenberg AM, Anegon I,. Zinc-finger nucleases: a powerful tool for genetic engineering of animals. Transgenic Res 2010; 19: 363-371.
34. Santiago Y, Chan E, Liu PQ, et al., Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proc Natl Acad Sci U S A 2008; 105: 5809-5814. (Pubitemid 351758454)
35. Argaw T, Ritzhaupt A, Wilson CA,. Development of a real time quantitative PCR assay for detection of porcine endogenous retrovirus. J Virol Methods 2002; 106: 97-106. (Pubitemid 35279654)
36. Blusch JH, Roos C, Nitschko H,. A polymerase chain reaction-based protocol for the detection of transmission of pig endogenous retroviruses in pig to human xenotransplantation. Transplantation 2000; 69: 2167-2172. (Pubitemid 30395055)
37. Ma Y, Yang Y, Lv M, et al., Real-time quantitative polymerase chain reaction with SYBR green I detection for estimating copy numbers of porcine endogenous retrovirus from Chinese miniature pigs. Transplant Proc 2010; 42: 1949-1952.
38. Switzer WM, Shanmugam V, Chapman L, Heneine W,. Polymerase chain reaction assays for the diagnosis of infection with the porcine endogenous retrovirus and the detection of pig cells in human and nonhuman recipients of pig xenografts. Xenotransplantation 1999; 68: 183-188. (Pubitemid 29360273)
39. Seifarth W, Spiess B, Zeilfelder U, et al., Assessment of retroviral activity using a universal retrovirus chip. J Virol Methods 2003; 112: 79-91. (Pubitemid 37338261)
40. Tacke S, Bodusch K, Berg A, Denner J,. Sensitive and specific detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation 2001; 8: 125-135. (Pubitemid 32336222)
41. Xu H, Sharma A, Okabe J, et al., Serologic analysis of anti-porcine endogenous retroviruses immune responses in humans after ex vivo transgenic pig liver perfusion. ASAIO J 2003; 49: 407-416. (Pubitemid 36898979)
42. Matthews AL, Brown J, Switzer W, et al., Development and validation of a Western immunoblot assay for detection of antibodies to porcine endogenous retrovirus. Transplantation 1999; 67: 939-943. (Pubitemid 29200841)
43. Galbraith DN, Kelly HT, Dyke A, et al., Design and validation of immunological tests for the detection of porcine endogenous retrovirus in biological materials. J Virol Methods 2000; 90: 115-124.
44. Paradis K, Langford G, Long Z, et al., Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999; 285: 1236-1241. (Pubitemid 29398604)
45. Garkavenko O, Dieckhoff B, Wynyard S, et al., Absence of transmission of potentially xenotic viruses in a prospective pig to primate islet xenotransplantation study. J Med Virol 2008; 80: 2046-2052.
46. Switzer WM, Michler RE, Shanmugam V, et al., Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation 2001; 71: 959-965. (Pubitemid 32417359)
47. Duchini A, Goss JA, Karpen S, Pockros PJ,. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003; 16: 357-364. (Pubitemid 36871311)
48. HIV assays: operational characteristics. World Health Organisation 2009.
49. Schüpbach J, Gebhardt MD, Tomasik Z, et al., Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation. PLoS Med 2007; 4: e343.
50. Langhammer S, Hübner J, Jarrett O, Kurth R, Denner J,. Immunization with the transmembrane protein of a retrovirus, feline leukemia virus: absence of antigenemia following challenge. Antiviral Res 2011; 89: 119-123.
51. Gomes-Keller MA, Gonczi E, Tandon R, et al., Detection of feline leukemia virus RNA in saliva from naturally infected cats and correlation of PCR results with those of current diagnostic methods. J Clin Microbiol 2006; 44: 916-922.
52. Denner J,. Detection of a gammaretrovirus, XMRV, in the human population: open questions and implications for xenotransplantation. Retrovirology 2010; 7: 16.
53. Kaiser J,. Chronic fatigue syndrome. Studies point to possible contamination in XMRV findings. Science 2011; 331: 17.
54. Smith RA,. Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology 2010; 7: 112.
55. Hué S, Gray ER, Gall A, et al., Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010; 7: 111.
56. Sato E, Furuta RA, Miyazawa T,. An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology 2010; 7: 110.
57. Hohn O, Krause H, Barbarotto P, et al., Lack of evidence for XMRV in prostate cancer biopsies from German patients. Retrovirology 2009; 6: 92.
58. Millard AL, Mueller NJ,. Can human viruses infect porcine xenografts? Xenotransplantation 2010; 17: 6.
59. Millard AL, Häberli L, Sinzger C, et al., Efficiency of porcine endothelial cell infection with human cytomegalovirus depends on both virus tropism and endothelial cell vascular origin. Xenotransplantation 2010; 17: 274.
60. Karlas A, Irgang M, Votteler J, et al., Characterisation of a human cell-adapted porcine endogenous retrovirus PERV-A/C. Ann Transplant 2010; 15: 45.